Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Akseli Hemminki

Showing results (91-100 of 280) with videos related to

Pageof 28
Sort By:
Current Pharmaceutical Biotechnology|July 12, 2011
Oncolytic viruses for induction of anti-tumor immunityAlex W Tong, Neil Senzer, Vincenzo Cerullo, et al.
Pigment Cell & Melanoma Research|February 4, 2020
Association between tumor characteristics and second primary cancers with cutaneous melanoma survival: A nationwide cohort studyGuoqiao Zheng, Subhayan Chattopadhyay, Kristina Sundquist, et al.
Clinical Epidemiology|March 12, 2020
Second Primary Cancers in Melanoma Patients Critically Shorten SurvivalGuoqiao Zheng, Subhayan Chattopadhyay, Kristina Sundquist, et al.
Cancer|January 30, 2023
Autoimmune diseases as comorbidities for liver, gallbladder, and biliary duct cancers in SwedenKari Hemminki, Kristina Sundquist, Jan Sundquist, et al.
Thorax|February 26, 2026
Increase in second primary lung cancers in a nation-wide cohort study from SwedenFrantisek Zitricky, Kristina Sundquist, Jan Sundquist, et al.
Annals of Translational Medicine|July 11, 2026
Does lung adenocarcinoma subtyping offer clinical benefits?-a retrospective population-based cohort study from SwedenFrantisek Zitricky, Kristina Sundquist, Jan Sundquist, et al.
Cancer Gene Therapy|July 23, 2003
Production of an EGFR targeting molecule from a conditionally replicating adenovirus impairs its oncolytic potentialAkseli Hemminki, Minghui Wang, Tanja Hakkarainen, et al.
Molecular Cancer Therapeutics|December 13, 2002
Conditionally replicative adenoviruses for ovarian cancer therapyMack N Barnes, Candace J Coolidge, Akseli Hemminki, et al.
European Journal of Endocrinology|September 7, 2023
Early mortality critically impedes improvements in thyroid cancer survival through a half centuryFilip Tichanek, Asta Försti, Vaclv Liska, et al.
Familial Cancer|May 11, 2026
Familial risks in prostate cancer between brothers and half-brothers as clues to germline genetic and environmental causesKari Hemminki, Frantisek Zitricky, Kristina Sundquist, et al.
Pageof 28

Showing results (91-100 of 280) with videos related to

Sort By:
Pageof 28
Current Pharmaceutical Biotechnology|July 12, 2011
Oncolytic viruses for induction of anti-tumor immunityAlex W Tong, Neil Senzer, Vincenzo Cerullo, et al.
Pigment Cell & Melanoma Research|February 4, 2020
Association between tumor characteristics and second primary cancers with cutaneous melanoma survival: A nationwide cohort studyGuoqiao Zheng, Subhayan Chattopadhyay, Kristina Sundquist, et al.
Clinical Epidemiology|March 12, 2020
Second Primary Cancers in Melanoma Patients Critically Shorten SurvivalGuoqiao Zheng, Subhayan Chattopadhyay, Kristina Sundquist, et al.
Cancer|January 30, 2023
Autoimmune diseases as comorbidities for liver, gallbladder, and biliary duct cancers in SwedenKari Hemminki, Kristina Sundquist, Jan Sundquist, et al.
Thorax|February 26, 2026
Increase in second primary lung cancers in a nation-wide cohort study from SwedenFrantisek Zitricky, Kristina Sundquist, Jan Sundquist, et al.
Annals of Translational Medicine|July 11, 2026
Does lung adenocarcinoma subtyping offer clinical benefits?-a retrospective population-based cohort study from SwedenFrantisek Zitricky, Kristina Sundquist, Jan Sundquist, et al.
Cancer Gene Therapy|July 23, 2003
Production of an EGFR targeting molecule from a conditionally replicating adenovirus impairs its oncolytic potentialAkseli Hemminki, Minghui Wang, Tanja Hakkarainen, et al.
Molecular Cancer Therapeutics|December 13, 2002
Conditionally replicative adenoviruses for ovarian cancer therapyMack N Barnes, Candace J Coolidge, Akseli Hemminki, et al.
European Journal of Endocrinology|September 7, 2023
Early mortality critically impedes improvements in thyroid cancer survival through a half centuryFilip Tichanek, Asta Försti, Vaclv Liska, et al.
Familial Cancer|May 11, 2026
Familial risks in prostate cancer between brothers and half-brothers as clues to germline genetic and environmental causesKari Hemminki, Frantisek Zitricky, Kristina Sundquist, et al.
Pageof 28